"The Riverside Center for Excellence in Aging and Lifelong Health (CEALH), originally The Center for Excellence in Aging and Geriatric Health, was incorporated in 2002 under the guidance of The Crossroads Group. This group was a collaboration between community and government organizations that had identified a gap in the conversion of research into application for the older adult population."

During the past decade, The Center for Excellence in Aging and Geriatric Health conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Center for Excellence in Aging and Geriatric Health" #1 sponsor was "Epix Pharmaceuticals, Inc." with 2 trials, followed by "FORUM Pharmaceuticals Inc" with 1 trials sponsored, "Molecular Research Center, Inc." with 1 trials sponsored, "Novartis" with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Center for Excellence in Aging and Geriatric Health" #1 collaborator was "BARC Global Central Laboratory" with 1 trials as a collaborator, "Bilcare Global Clinical Supplies" with 1 trials as a collaborator, "Camargo Pharmaceutical Services" with 1 trials as a collaborator, "Clin Data Services" with 1 trials as a collaborator and "Harrison Clinical Research" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "The Center for Excellence in Aging and Geriatric Health" are "Alzheimer's Disease" (5 trials), "Arthritis, Rheumatoid" (1 trials), "Central Nervous System Diseases" (1 trials), "Cognition" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "The Center for Excellence in Aging and Geriatric Health" in a lesser frequency.

Most popular intervention types in "The Center for Excellence in Aging and Geriatric Health" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "PRX-03140" (2 trials), "AC-3933" (1 trials), "Donepezil" (1 trials) and "EVP-6124" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Center for Excellence in Aging and Geriatric Health" are 7 trials for "All" genders.

Currently, there are NaN active trials in "The Center for Excellence in Aging and Geriatric Health". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in The Center for Excellence in Aging and Geriatric Health, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The Center for Excellence in Aging and Geriatric Health, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".